Who Will Get the Covid Vaccine First? A New Tool Aims to Help States Decide

When the coronavirus vaccine arrives on the market, demand will far exceed supply.

When the coronavirus vaccine arrives on the market, demand will far exceed supply. Shutterstock

 

Connecting state and local government leaders

A tool developed by epidemiologists and data scientists can be used to help states and counties decide how to allocate limited vaccine doses to high risk populations.

When the coronavirus vaccine arrives on the market, demand will far exceed supply. During those first few months, state and county public health officials will face tough questions about who should be first in line to get one of the limited vaccine doses. The Vaccine Allocation Planner for Covid-19, a new tool released Wednesday, aims to help make those decisions with data. 

Jointly developed by Ariadne Labs, a project run out of Brigham and Women’s Hospital and the Harvard T.H. Chan School of Public Health, and the Surgo Foundation, a nonprofit at the intersection of behavioral and data science, the tool allows policymakers to look at region-specific data. They can estimate the size of high-risk populations, consider factors like particular community’s vulnerabilities, and run scenarios based on an estimated number of vaccine doses available.

Using data from the census, the Centers for Disease Control and Prevention, and the Bureau of Labor Statistics, local leaders can identify which counties have the most individuals at risk to catch the coronavirus and suffer complications from it. It also allows state and county governments to set aside portions of their vaccine stock to geographic areas where whole communities might be more vulnerable due to a lack of access to health care or tough socioeconomic circumstances.

Sema Sgaier, the executive director of the Surgo Foundation, said that the tool can make the challenge of vaccine distribution more manageable. “State and local leaders are going to need to make decisions about how to distribute their allotted Covid-19 vaccine doses, and there are many permutations those decisions could take,” she said in a statement. “Our tool gives them the concrete, localized data they will need to estimate with precision and maximize the public health impact of the coronavirus vaccine, while at the same time prioritizing vulnerable populations.”

This month, states turned in rough drafts of their plans for distributing vaccines to the CDC, with leaders emphasizing that there is still a lot to plan for and many variables still up in the air. For example, the different vaccines being developed will require different levels of refrigeration and, right now, it isn’t clear which ones will get approved by the federal government. It’s also expected that people will be required to get two shots, which will complicate rollout plans.

The allocation tool utilizes guidelines recently released by the National Academies of Sciences, Engineering, and Medicine, which separate vaccine distribution into four phases based on the risk of people catching and spreading the disease in the initial period of time when demand for the vaccine will exceed supply. 

The first phase prioritizes first responders and front-line health workers in hospitals, nursing homes, or those who are providing home care. Researchers noted that it is critical to prioritize this group as they have “a critical role in maintaining health care system functionality, high risk of exposure to patients exhibiting symptoms of Covid-19, and higher risk of then transmitting the virus to others, including family members.” In the second part of phase one, people with serious underlying conditions like cancer and heart problems would be prioritized, along with those over the age of 65 who are living in communal housing like nursing homes, homeless shelters, and prisons. Combined, these groups make up about 15% of the U.S. population. 

The second phase would cover an additional 30% to 35% of the population, and would include essential workers like school staff and child care workers, public transit operators, and those who work at grocery stores. Also included in this phase are people who have more mild underlying health conditions, people of all ages living in communal settings, and anyone over 65 who was not included in phase one.

Phase three would bring in another 40% to 45% of the population through the vaccination of remaining critical workers at colleges, hotels, and gyms, all of which have a strong potential to be outbreak vectors. Children and young adults between the ages of 18 and 30 would also be targeted in this phase, as they “typically have broader social networks than older adults, increasing their risks of infection and transmission.” Phase four would expand vaccine access to anyone who hasn’t already gotten vaccinated in the prior phases.

NASEM Committee Co-chair Dr. Helene Gayle said that the four-phased approach will still leave some uncertainties that state and local leaders will have to plan for. “This tool helps them do that, providing the most reliable estimates of high-priority populations and allowing them to weigh that data against potential scenarios,” she said in a statement.

Since the beginning of the pandemic, those who worked on the roll out of the H1N1 vaccine in 2009 have urged local leaders to think about different scenarios for vaccine distribution as soon as possible, so that the eventual rollout of an approved vaccine can be smoother and more targeted to those who need it most.

Even for those with a jump on planning, it’s likely the biggest challenge facing local governments will be funding the vaccine rollout. The CDC has allocated $200 million to jurisdictions for vaccine preparedness, but much of that hasn’t arrived at the local level yet. State and local governments are scrambling to figure out how to pay for distribution systems that the CDC says need to be set up by Nov. 1. After that, it’s a waiting game until a vaccine is developed and approved. Most experts predict a vaccine won’t be in wide distribution until mid-2021 at the earliest.

Earlier in the month, New York Gov. Andrew Cuomo and Arkansas Gov. Asa Hutchinson, the leaders of the National Governors Association, wrote to President Trump asking for clarification about the vaccine rollout process and associated funding for it. "We need to know: What is the plan?" Cuomo said on October 15. "Let's figure it out now because this virus has been ahead of us every step of the way — it's about time this country catches up."

Emma Coleman is the assistant editor for Route Fifty.

FEATURED CASE STUDIES
Powered By The Atlas
Corpus Christi Deploys COVID Management System to Improve Data & Eliminate Time-Consuming Tasks
Corpus Christi, TX, USA
Safer Holiday Celebrations Connect Residents and Support Local Business in Franklin, TN
Franklin, TN, USA
Mobile-first Crisis Communications in Dublin, OH
Dublin, OH, USA

NEXT STORY: The Difference Between Feeling Safe and Being Safe

X
This website uses cookies to enhance user experience and to analyze performance and traffic on our website. We also share information about your use of our site with our social media, advertising and analytics partners. Learn More / Do Not Sell My Personal Information
Accept Cookies
X
Cookie Preferences Cookie List

Do Not Sell My Personal Information

When you visit our website, we store cookies on your browser to collect information. The information collected might relate to you, your preferences or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. However, you can choose not to allow certain types of cookies, which may impact your experience of the site and the services we are able to offer. Click on the different category headings to find out more and change our default settings according to your preference. You cannot opt-out of our First Party Strictly Necessary Cookies as they are deployed in order to ensure the proper functioning of our website (such as prompting the cookie banner and remembering your settings, to log into your account, to redirect you when you log out, etc.). For more information about the First and Third Party Cookies used please follow this link.

Allow All Cookies

Manage Consent Preferences

Strictly Necessary Cookies - Always Active

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data, Targeting & Social Media Cookies

Under the California Consumer Privacy Act, you have the right to opt-out of the sale of your personal information to third parties. These cookies collect information for analytics and to personalize your experience with targeted ads. You may exercise your right to opt out of the sale of personal information by using this toggle switch. If you opt out we will not be able to offer you personalised ads and will not hand over your personal information to any third parties. Additionally, you may contact our legal department for further clarification about your rights as a California consumer by using this Exercise My Rights link

If you have enabled privacy controls on your browser (such as a plugin), we have to take that as a valid request to opt-out. Therefore we would not be able to track your activity through the web. This may affect our ability to personalize ads according to your preferences.

Targeting cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Social media cookies are set by a range of social media services that we have added to the site to enable you to share our content with your friends and networks. They are capable of tracking your browser across other sites and building up a profile of your interests. This may impact the content and messages you see on other websites you visit. If you do not allow these cookies you may not be able to use or see these sharing tools.

If you want to opt out of all of our lead reports and lists, please submit a privacy request at our Do Not Sell page.

Save Settings
Cookie Preferences Cookie List

Cookie List

A cookie is a small piece of data (text file) that a website – when visited by a user – asks your browser to store on your device in order to remember information about you, such as your language preference or login information. Those cookies are set by us and called first-party cookies. We also use third-party cookies – which are cookies from a domain different than the domain of the website you are visiting – for our advertising and marketing efforts. More specifically, we use cookies and other tracking technologies for the following purposes:

Strictly Necessary Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Functional Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Performance Cookies

We do not allow you to opt-out of our certain cookies, as they are necessary to ensure the proper functioning of our website (such as prompting our cookie banner and remembering your privacy choices) and/or to monitor site performance. These cookies are not used in a way that constitutes a “sale” of your data under the CCPA. You can set your browser to block or alert you about these cookies, but some parts of the site will not work as intended if you do so. You can usually find these settings in the Options or Preferences menu of your browser. Visit www.allaboutcookies.org to learn more.

Sale of Personal Data

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Social Media Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.

Targeting Cookies

We also use cookies to personalize your experience on our websites, including by determining the most relevant content and advertisements to show you, and to monitor site traffic and performance, so that we may improve our websites and your experience. You may opt out of our use of such cookies (and the associated “sale” of your Personal Information) by using this toggle switch. You will still see some advertising, regardless of your selection. Because we do not track you across different devices, browsers and GEMG properties, your selection will take effect only on this browser, this device and this website.